13F Holdings
中文EN

NAII NATURAL ALTERNATIVES INTERNATIONAL INC

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 787253 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.1%
TTM net income YoY-92.6%
TTM EPS YoY-89.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin4.4%
Operating margin-16.3%
Net margin-17.2%
FCF margin-5.0%
EBITDA margin-12.8%

Returns

ROE-39.4%
ROA-16.9%
ROIC (approx.)-30.3%
Asset turnover0.98x

Leverage & solvency

Liabilities / assets58.8%
Debt / equity0.23x
Current ratio1.37x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.16x
Accruals ratio-14.1%
Payout ratio—
Capex / revenue2.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue$142.51M$129.86M$113.80M$154.01M$170.97M
Cost of revenue$133.52M$120.57M$106.93M$135.86M$140.46M
Gross profit$9.00M$9.29M$6.87M$18.16M$30.51M
R&D expense$2.30M$1.80M$1.90M$2.10M$2.50M
Operating income-$18.75M-$8.66M-$8.53M$4.71M$13.68M
Pretax income-$20.27M-$10.74M-$9.46M$3.56M$13.66M
Income tax$430,000$2.83M-$2.25M$1.03M$2.95M
Net income-$20.70M-$13.57M-$7.22M$2.52M$10.71M
EBITDA-$14.04M-$4.10M-$3.89M$8.96M$17.84M
EPS (basic)-3.43-2.28-1.230.431.75
EPS (diluted)-3.43-2.28-1.230.431.74
Weighted avg. shares (diluted)6.03M5.95M5.87M5.88M6.16M
Banking
Net interest income-$1.19M-$915,000-$361,000-$451,000-$83,000
Balance sheet
Cash & equivalents$7.39M$12.32M$11.98M$13.60M$21.83M
Receivables$20.65M$14.64M$16.89M$7.02M$17.42M
Inventory$30.75M$24.87M$24.25M$29.69M$32.48M
Current assets$65.43M$59.28M$61.61M$57.01M$76.75M
PP&E, net$35.60M$50.89M$52.21M$53.84M$44.57M
Total assets$126.45M$151.94M$162.34M$134.15M$146.00M
Current liabilities$37.72M$28.80M$23.46M$15.88M$23.89M
Long-term debt$10.90M————
Total debt$10.90M————
Total liabilities$76.49M$83.51M$79.75M$45.38M$57.48M
Shareholders' equity$49.96M$68.43M$82.59M$88.77M$88.52M
Net debt$3.51M————
Shares outstanding6.27M6.18M6.20M6.07M6.13M
Cash flow statement
Operating cash flow-$8.92M$5.93M-$1.50M$7.02M$11.87M
Capital expenditure$3.70M$3.61M$3.02M$13.52M$26.49M
Free cash flow-$12.62M$2.32M-$4.51M-$6.50M-$14.62M
Investing cash flow-$3.70M-$3.61M-$3.02M-$13.47M-$26.46M
Financing cash flow$7.77M-$1.97M$2.89M-$1.78M$4.29M
Depreciation & amortization$4.71M$4.56M$4.65M$4.25M$4.17M
Stock-based compensation$603,000$977,000$1.20M$1.01M$968,000
Share buybacks$89,000$178,000$221,000$1.50M$5.50M

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.